Crossref Citations
This Book has been
cited by the following publications. This list is generated based on data provided by Crossref.
Duckett, Stephen
and
Swerissen, Hal
1996.
Specific Purpose Programs in Human Services and Health: Moving from an Input to an Output and Outcome Focus.
Australian Journal of Public Administration,
Vol. 55,
Issue. 3,
p.
7.
Parmigiani, Giovanni
Samsa, Greg P.
Ancukiewicz, Marek
Lipscomb, Joseph
Hasselblad, Vic
and
Matchar, David B.
1997.
Assessing Uncertainty in Cost-Effectiveness Analyses.
Medical Decision Making,
Vol. 17,
Issue. 4,
p.
390.
Torfs, K.
1997.
Economic aspects of treatment for fungal infections in cancer patients.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 16,
Issue. 1,
p.
98.
Rodriguez, Javier
and
Borgen, William A.
1998.
Needs Assessment.
Employee Assistance Quarterly,
Vol. 14,
Issue. 2,
p.
11.
Ørnskov, Flemming
1998.
Zeitfragen der Medizin.
p.
205.
Landry, Diane Watson
and
Mathews, Maria
1998.
Economic Evaluation of Occupational Therapy: Where are We at?.
Canadian Journal of Occupational Therapy,
Vol. 65,
Issue. 3,
p.
160.
Breyer, Friedrich
and
Zweifel, Peter
1999.
Gesundheitsökonomie.
p.
19.
Gordon, Caroline
and
Clarke, Ann E
1999.
Quality of life and economic evaluation in SLE clinical trials.
Lupus,
Vol. 8,
Issue. 8,
p.
645.
Crawford, Gregory S.
and
Shum, Matthew
1999.
Uncertainty and Experimentation in Pharmaceutical Demand: Anti-Ulcer Drugs.
SSRN Electronic Journal ,
Colombo, Giorgio L.
Dobrilla, G.
Capurso, L.
Curzio, M.
Vigneri, S.
and
Vinci, M.
2000.
I costi nella gestione del paziente con dispepsia funzionale.
PharmacoEconomics Italian Research Articles,
Vol. 2,
Issue. 1,
p.
29.
Ozminkowski, Ronald J.
and
Goetzel, Ron Z.
2001.
Getting Closer to the Truth: Overcoming Research Challenges When Estimating the Financial Impact of Worksite Health Promotion Programs.
American Journal of Health Promotion,
Vol. 15,
Issue. 5,
p.
289.
Colombo, Giorgio L.
Nicosia, V.
Lesma, A.
Madera, A.
Caruggi, M.
and
Serra, G.
2001.
Analisi costi-benefici di una strategia vaccinale antinfluenzale condotta presso una società del gruppo ENI (Snamprogetti).
PharmacoEconomics Italian Research Articles,
Vol. 3,
Issue. 2,
p.
71.
Levin, Henry
2001.
Waiting for Godot: Cost‐Effectiveness Analysis in Education.
New Directions for Evaluation,
Vol. 2001,
Issue. 90,
p.
55.
Arguedas, Miguel R.
Dupont, Andrew W.
and
Wilcox, C. Mel
2001.
Where do ERCP, endoscopic ultrasound, magnetic resonance cholangiopancreatography, and intraoperative cholangiography fit in the management of acute biliary pancreatitis? A decision analysis model.
The American Journal of Gastroenterology,
Vol. 96,
Issue. 10,
p.
2892.
Colombo, Giorgio L.
Serra, G.
and
Terranova, L.
2001.
Indagine sulla diffusione della farmacoeconomia nell’industria farmaceutica che opera in Italia.
PharmacoEconomics Italian Research Articles,
Vol. 3,
Issue. 2,
p.
91.
Harewood, Gavin C.
and
Wiersema, Maurits J.
2001.
A cost analysis of endoscopic ultrasound in the evaluation of pancreatic head adenocarcinoma.
The American Journal of Gastroenterology,
Vol. 96,
Issue. 9,
p.
2651.
Badura, Bernhard
Schaeffer, Doris
and
Troschke, Jürgen v.
2001.
Versorgungsforschung in Deutschland Fragestellungen und Förderbedarf.
Journal of Public Health,
Vol. 9,
Issue. 4,
p.
294.
Paltiel, A. David
2001.
Model-Based Drug Evaluation in Chronic Disease: Promise, Pitfalls, and Positioning.
Drug Information Journal,
Vol. 35,
Issue. 1,
p.
131.
Harewood, Gavin C.
and
Wiersema, Maurits J.
2002.
A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer.
The American Journal of Gastroenterology,
Vol. 97,
Issue. 2,
p.
452.
Parmigiani, G
2002.
Measuring uncertainty in complex decision analysis models.
Statistical Methods in Medical Research,
Vol. 11,
Issue. 6,
p.
513.